Psychiatric and neurodevelopmental disorders may arise from anomalies in long-range neuronal connectivity downstream of pathologies in dendritic spines. However, the mechanisms that may link spine pathology to circuit abnormalities relevant to atypical behavior remain unknown. Using a mouse model to conditionally disrupt a critical regulator of the dendritic spine cytoskeleton, the actin-related protein 2/3 complex (Arp2/3), we report here a molecular mechanism that unexpectedly reveals the inter-relationship of progressive spine pruning, elevated frontal cortical excitation of pyramidal neurons and striatal hyperdopaminergia in a cortical-to-midbrain circuit abnormality. The main symptomatic manifestations of this circuit abnormality are psychomotor agitation and stereotypical behaviors, which are relieved by antipsychotics. Moreover, this antipsychotic-responsive locomotion can be mimicked in wild-type mice by optogenetic activation of this circuit. Collectively these results reveal molecular and neural-circuit mechanisms, illustrating how diverse pathologies may converge to drive behaviors relevant to psychiatric disorders.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Molecular Psychiatry Open Access 11 April 2023
Neuropsychopharmacology Open Access 30 September 2022
Molecular Psychiatry Open Access 11 May 2022
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014).
Lee, S.H. et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 44, 247–250 (2012).
Malhotra, D. & Sebat, J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148, 1223–1241 (2012).
Stergiakouli, E. et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am. J. Psychiatry 169, 186–194 (2012).
McCarroll, S.A. & Hyman, S.E. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron 80, 578–587 (2013).
Hyman, S.E. Perspective: revealing molecular secrets. Nature 508, S20 (2014).
Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184 (2014).
Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142–153 (2012).
Chang, J., Gilman, S.R., Chiang, A.H., Sanders, S.J. & Vitkup, D. Genotype to phenotype relationships in autism spectrum disorders. Nat. Neurosci. 18, 191–198 (2015).
Han, K. et al. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503, 72–77 (2013).
Durand, C.M. et al. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol. Psychiatry 17, 71–84 (2012).
Won, H. et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat. Med. 17, 566–572 (2011).
Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327–332 (2010).
Carlson, B.R. et al. WRP/srGAP3 facilitates the initiation of spine development by an inverse F-BAR domain, and its loss impairs long-term memory. J. Neurosci. 31, 2447–2460 (2011).
Govek, E.E. et al. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 7, 364–372 (2004).
Meng, Y. et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 35, 121–133 (2002).
Gu, Z., Jiang, Q., Fu, A.K., Ip, N.Y. & Yan, Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 25, 4974–4984 (2005).
De Rubeis, S. et al. CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation. Neuron 79, 1169–1182 (2013).
Clement, J.P. et al. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151, 709–723 (2012).
Russell, T.A. et al. A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness. Nat. Commun. 5, 4858 (2014).
Vaags, A.K. et al. Absent CNKSR2 causes seizures and intellectual, attention, and language deficits. Ann. Neurol. 76, 758–764 (2014).
Koleske, A.J. Molecular mechanisms of dendrite stability. Nat. Rev. Neurosci. 14, 536–550 (2013).
Penzes, P., Cahill, M.E., Jones, K.A., VanLeeuwen, J.E. & Woolfrey, K.M. Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285–293 (2011).
Mullins, R.D., Stafford, W.F. & Pollard, T.D. Structure, subunit topology, and actin-binding activity of the Arp2/3 complex from Acanthamoeba. J. Cell Biol. 136, 331–343 (1997).
Kim, I.H. et al. Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities. J. Neurosci. 33, 6081–6092 (2013).
van den Buuse, M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36, 246–270 (2010).
Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427–436 (1999).
Hoffman, D.C. & Donovan, H. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology (Berl.) 120, 128–133 (1995).
Creese, I., Burt, D.R. & Snyder, S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481–483 (1976).
Tsien, J.Z. et al. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87, 1317–1326 (1996).
Ungerstedt, U. & Arbuthnott, G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485–493 (1970).
Watabe-Uchida, M., Zhu, L., Ogawa, S.K., Vamanrao, A. & Uchida, N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74, 858–873 (2012).
Sesack, S.R. & Pickel, V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320, 145–160 (1992).
Parker, J.G., Beutler, L.R. & Palmiter, R.D. The contribution of NMDA receptor signaling in the corticobasal ganglia reward network to appetitive Pavlovian learning. J. Neurosci. 31, 11362–11369 (2011).
Kato, S. et al. A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein. Hum. Gene Ther. 22, 197–206 (2011).
Ke, M.T., Fujimoto, S. & Imai, T. SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction. Nat. Neurosci. 16, 1154–1161 (2013).
Harnett, M.T., Makara, J.K., Spruston, N., Kath, W.L. & Magee, J.C. Synaptic amplification by dendritic spines enhances input cooperativity. Nature 491, 599–602 (2012).
Tønnesen, J., Katona, G., Rozsa, B. & Nagerl, U.V. Spine neck plasticity regulates compartmentalization of synapses. Nat. Neurosci. 17, 678–685 (2014).
Yuste, R. Electrical compartmentalization in dendritic spines. Annu. Rev. Neurosci. 36, 429–449 (2013).
Laruelle, M. et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. USA 93, 9235–9240 (1996).
Belforte, J.E. et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13, 76–83 (2010).
Gainetdinov, R.R., Mohn, A.R. & Caron, M.G. Genetic animal models: focus on schizophrenia. Trends Neurosci. 24, 527–533 (2001).
Ballard, I.C. et al. Dorsolateral prefrontal cortex drives mesolimbic dopaminergic regions to initiate motivated behavior. J. Neurosci. 31, 10340–10346 (2011).
Insel, T.R. Rethinking schizophrenia. Nature 468, 187–193 (2010).
Lawrie, S.M. et al. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol. Psychiatry 51, 1008–1011 (2002).
Ford, J.M., Mathalon, D.H., Whitfield, S., Faustman, W.O. & Roth, W.T. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol. Psychiatry 51, 485–492 (2002).
Yizhar, O. et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171–178 (2011).
Sun, D. et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 108, 85–92 (2009).
McIntosh, A.M. et al. Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biol. Psychiatry 69, 953–958 (2011).
Glausier, J.R. & Lewis, D.A. Dendritic spine pathology in schizophrenia. Neuroscience 251, 90–107 (2013).
Nelson, A. et al. A circuit for motor cortical modulation of auditory cortical activity. J. Neurosci. 33, 14342–14353 (2013).
Kim, I.H., Wang, H., Soderling, S.H. & Yasuda, R. Loss of Cdc42 leads to defects in synaptic plasticity and remote memory recall. Elife 3, e02839 (2014).
Kim, I.H. et al. Inositol 1,4,5-trisphosphate 3-kinase a functions as a scaffold for synaptic Rac signaling. J. Neurosci. 29, 14039–14049 (2009).
Rossi, M.A. et al. Prefrontal cortical mechanisms underlying delayed alternation in mice. J. Neurophysiol. 108, 1211–1222 (2012).
We thank M. Caron, B. Hogan and C. Eroglu for critical reading and comments. We also thank K. Kobayashi (Fukushima Medical University, Japan) for providing the FuGB2 viral vector, K. Sakurai (Duke University) for providing the hSyn-Cre lentiviral vector, and R. Rodriguiz and E. Spence for behavioral technical support. This work was supported by the following grants: US National Institutes of Health (NIH) MH103374 and NS059957 (S.H.S.), NIH NS077986 (F.W.), AA021074 (H.Y.), NS039444 (R.J.W.) and MH082441 (W.C.W.). M.R. is supported by a US National Research Foundation fellowship and B.R. is supported by the János Bólyai Research Fellowship from the Hungarian Academy of Sciences, by the Hungarian Scientific Research Fund (OTKA, grant K83830) and by the Szent István University, Faculty of Veterinary Science (Research Faculty Grant 2014). Some of the experiments were conducted with equipment/software purchased with a North Carolina Biotechnology Center grant (W.C.W.).
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 Elevated vertical activity and stereotypical behavior in the Arp2/3 mutant mouse is normalized by antipsychotics, and re-plots of data from Figure 1 of haloperidol and clozapine in control mice.
(a) Open field analysis of rearing over time for Arp2/3 mutant (ArpC3f/f:CaMKIIαCre) or control (ArpC3f/f) mice given an intraperitoneal injection of vehicle (saline) or drug (haloperidol or clozapine) at 60min (arrow). (b) Cumulative vertical beam breaks per hour from (a) for each condition (*ps<0.05; two-way ANOVA with repeated measure followed by post-hoc tests). (c) Analysis of stereotypical activity (repeated beam breaks) in the open field over time for Arp2/3 mutant (ArpC3f/f:CaMKIIαCre) or control (ArpC3f/f) mice given (i.p.) of vehicle (saline) or drug (haloperidol or clozapine) at 60min (arrow). (d) Cumulative stereotypical activity per hour from (c) for each condition (*ps<0.05; two-way ANOVA with repeated measure followed by post-hoc tests). n=12-21. Each condition is color-coded according the key (top). Open field analysis of (e) distance traveled, (f) vertical activity, or (g) stereotypical activity over time for control (ArpC3f/f) mice given (i.p.) vehicle (saline) or drug (haloperidol or clozapine) at 60 min (dotted line). Each condition is color-coded according the key (top). @, #, and $ indicate statistical significances [@, vehicle vs. haloperidol (0.2mg/kg); #, vehicle vs. haloperidol (0.1mg/kg); $, vehicle vs. clozapine (0.5mg/kg)] in one way ANOVA with repeated measure followed by Bonferroni pair-wise comparisons. n=12-15. Data are presented as mean ±SEM. Detailed statistical analyses can be found in Supplementary Table 1.
Supplementary Figure 2 Camk2a-cre:Rosa26Tomato mouse (p42) shows Camk2a promoter–driven expression of Cre recombinase predominately in the cortex, with little expression in striatum, and acute haloperidol treatment does not rescue the spine density of Arp2/3 mutant mice.
(a) Schematic represents the regions of images in b-c of frontal cortex and striatum. (b-c) Representative images of Cre-dependent expression of RosaTomato (left panel), or DAPI stain (middle panel), and the merged images (right panel) from the frontal cortex (b) and the striatum (c). (d) Representative images of Golgi stained dendritic segments from the frontal cortical region (layers 3-5) of control (ArpC3f/f, top panel) (n=5), or Arp2/3 mutant mice (ArpC3f/f:CaMKIIαCre) treated with vehicle (saline, middle panel; n=5), or haloperidol (0.2 mg/kg, bottom panel; n=5) at p120-150. Vehicle and haloperidol (0.2mg/kg) was treated (i.p.) 1hr before perfusion. (e) Graph the average density of spines from (a) for each condition. Data are presented as mean ±SEM. N.S.; not statistically significant. All representative images were successfully repeated more than three times. Detailed statistical analyses can be found in Supplementary Table 1.
Supplementary Figure 3 Representative images depicting the Cre-dependent specific expression of the Flex-AAV viruses, and Cre-dependent expression of the Flex-AAV-ChR2 in HEK293T cells and mouse brain.
(a-b) Infection of Flex-AAV-GFP viruses do not express GFP in HEK293T cells transfected with tdTomato (row a), but do in the cells that express tdTomato-Cre (row b). (c-d) Infection of Flex-AAV-ArpC3-2A-GFP viruses do not express GFP in HEK293T cells transfected with tdTomato (row c), but do in the cells that express tdTomato-Cre (row d). (e) Infection of AAV-Flex-ChR2-mCherry expresses mCherry in GFP-Cre-positive HEK293 cells. Inset represents a high-magnification view showing membrane-associated expression of ChR2-mCherry. (f) In contrast, AAV-Flex-ChR2-mCherry does not express mCherry in the absence of Cre expression. (g-h) Frontal cortex of (g) CaMKII a-Cre mouse infected with AAV-Flex-ChR2-mCherry for two weeks results in the expression of mCherry, but the same infection into (h) WT frontal cortex does not result in mCherry expression. (i) Infection of AAV-Flex-ChR2-YFP virus expresses mCherry in GFP-Cre-positive HEK293 cells. Inset represents a high-magnification view showing a membranous expression of ChR2-YFP. (j) However, AAV-Flex-ChR2-YFP does not express YFP without Cre expression. (k-l) Frontal cortex of (k) CaMKII a-Cre mouse infected with AAV-Flex-ChR2-YFP for two weeks results in expression of YFP, but the same infection into (l) WT frontal cortex does not result in YFP expression. All representative images were successfully repeated more than three times.
Supplementary Figure 4 Flex-AAV-mediated regional rescue (FARR) of the frontal cortex in the Arp2/3 mutant mice normalizes rearing activity and stereotypical behavior, whereas FARR of the frontal cortex in the Arp2/3 mutant mice does not normalize PPI.
(a) Mean vertical beam breaks in the open field every 5 min for ArpC3f/f (gray circle; n=18), ArpC3f/f:CaMKIIαCre-GFP (cKO-control) (orange triangle; n=11), and ArpC3f/f:CaMKIIαCre-ArpC3-2A-GFP (cKO-rescue) (green diamond; n=15) mice. (b) Mean stereotypical activity (repeated beam breaks) in the open field every 5 min for ArpC3f/f (gray circle), ArpC3f/f:CaMKIIαCre-GFP (cKO-control) (orange triangle), and ArpC3f/f:CaMKIIαCre-ArpC3-2A-GFP (cKO-rescue) (green diamond) mice. (c) Percent prepulse inhibition (PPI) of the acoustic startle responses to the 4, 8, and 12 dB prepulses [n=16 for ArpC3f/f (WT); n=20 for ArpC3f/f:CaMKIIαCre-GFP (cKO-control); n=15 for ArpC3f/f:CaMKIIαCre-ArpC3-2A-GFP (cKO-rescue)]. One-way ANOVA followed by post-hoc tests reveal that WT mice show significantly higher PPI compared to both cKO groups. However, there were no statistical differences between cKO-control and cKO-rescue throughout all dB groups (4dB, 8dB, and 12 dB). *ps<0.05. Data are presented as mean ±SEM. N.S., not statistically significant. Detailed statistical analyses can be found in Supplementary Table 1.
Supplementary Figure 5 FLEX-AAV-mediated regional rescue (FARR) of the hippocampus in the Arp2/3 mutant mice does not normalize behavior in the open field.
(a) Schematic representation of the bilateral Cre-dependent ArpC3 rescue virus injection into hippocampus. (b) Representative serial coronal images showing ArpC3-2A-GFP (green) expression from dorsal to ventral hippocampus. (c to h) Analysis of open field behaviors following bilateral hippocampal rescue of Arp2/3. (c, e, g) Mean (c) distance traveled, (e) vertical activity, and (g) stereotypical behavior every 5 min for ArpC3f/f (WT) (gray line; n=14), ArpC3f/f:CaMKIIαCre-GFP (cKO-control) (orange line; n=14), and ArpC3f/f:CaMKIIαCre-ArpC3-2A-GFP (cKO-rescue) (green line n=12) mice. (d, f, h) Cumulative (d) distance traveled (f), vertical activity, and (h) stereotypical behavior for each group. Data are presented as mean ±SEM. N.S., not statistically significant. Detailed statistical analyses can be found in Supplementary Table 1.
(a) Representative sagittal brain images showing the expressions of AAV-Synapsin I-GFP (top left) and AAV-CaMKII-Cre-GFP (top right) in frontal cortex (FC). Bottom panels showing the high-magnification views of top panels (red squares). Cre-GFP is predominantly expressed in the nucleus of frontal cortical cells (bottom right) compared to the cytoplasmic expression of GFP (bottom left). (b) Analysis of the locomotor activity of mice following bilateral infections of AAV-Synapsin I-GFP (control; gray line; n=16) or AAV-CaMKII-Cre-GFP (cKO; green line; n=14) in the frontal cortical region. One-way ANOVA with repeated measure followed by post-hoc tests reveal that Cre-GFP expressing mice show increased locomotor activity compared to GFP-expressing littermate controls from 25 to 60 min except at the 40 min time-point. *ps<0.05. Data are presented as mean ±SEM. Detailed statistical analyses can be found in Supplementary Table 1.
Supplementary Figure 7 Retrograde Cre expression by lenti-FuGB2-Cre virus, and ipsilateral projection of frontal cortex–VTA/SNc circuit.
(a) Schematic representation of the Lenti-FuGB2-Cre viral infection into the VTA/SNc of AI-14 Cre-reporter mouse. (b) Schematic illustration of tdTomato expression in a neuron which projects its axon into the VTA/SNc. (c) Infection of Lenti-FuGB2-Cre in VTA/SNc (white square) induces tdTomato expression in frontal cortical pyramidal neurons (yellow square) and striatal medium spiny neurons (sky blue square). Note that majority of tdTomato signals in VTA/SNc are cell body-free axonal fibers (white square). (d) Schematic representation of the circuit tracing based on a unilateral injection of Lenti-FuGB2-Cre virus into the VTA/SNc, followed by monitoring ipsilateral versus contralateral connectivity to the FC by bi-lateral injection of Flex-AAV-GFP. (e) Middle panel, image of a coronal section of the FC for GFP (green) and DAPI (blue). Boxed regions represent Left panel (ipsilateral image) and Right panel (contralateral image). All representative images were successfully repeated more than three times.
Supplementary Figure 8 Immunoelectron microscopy analyses of GABAergic synapses in the frontal cortex.
(a-b) Representative electron micrographs of GABAergic synapses (colored by blue) in the frontal cortical region of (a) ArpC3f/f and (b) ArpC3f/f:CaMKIIαCre mice. (c) Quantification of synapse density (n=43 micrographs from 3 mice for ArpC3f/f mice and n=46 micrographs from 3 mice for ArpC3f/f:CaMKIIαCre mice) (*p<0.001, independent t-test). Data are presented as mean ±SEM. Detailed statistical analyses can be found in Supplementary Table 1.
Supplementary Figure 9 cKO neurons display increased amplitude and frequency of mEPSCs in the frontal cortex.
Cumulative distribution of mEPSC (a) amplitude and (b) frequency. Each group [n=9 (10 DAI-WT; black line), n=10 (10 DAI-control; orange line), n=10 (10 DAI-rescue; blue line), n=15 (30 DAI-control; red line), n=15 (30 DAI-rescue; green line)] is color-coded according the key (center). DAI, days after infection. Detailed statistical analyses can be found in Supplementary Table 1.
Supplementary Figure 10 Schematic model proposing how loss of Arp2/3 activity leads to frontal cortical spine loss and increased locomotion via elevated dopamine in the striatum.
Progressive loss of spines downstream of Arp2/3 loss leads to abnormal synaptic contacts in the frontal cortex (FC; orange circle) (a), resulting in elevated frequency and amplitude of excitatory input of the KO neurons (b). This paradoxical excitation may enhance the activation of FC pyramidal neurons projecting to the VTA/SNc (c) that make synaptic contact with dopamine (DA) producing cells (blue circle) (d), leading to increased release of DA within the striatum (e). Finally, elevated levels of DA in the striatum provoke antipsychotic-responsive locomotor hyperactivity (f).
Supplementary Figures 1–10 and Supplementary Table 1 (PDF 14315 kb)
Green signals indicate pyramidal neurons and their axons from the frontal cortex. Red signals show tyrosine hydroxylase–positive dopamine neurons in the VTA/SNc. Blue puncta indicate sites of Vglut1-positive excitatory synaptic contacts. (MOV 29560 kb)
About this article
Cite this article
Kim, I., Rossi, M., Aryal, D. et al. Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine. Nat Neurosci 18, 883–891 (2015). https://doi.org/10.1038/nn.4015
This article is cited by
The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia
Molecular Psychiatry (2023)
Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia
Molecular Psychiatry (2022)